Řehulka Jiří Ph.D.
About me
Assistant professor at the Institute of Molecular and Translational Medicine. He is involved in drug screening, confocal microscopy and image analysis. His research interests are microtubule targeting agents and mechanisms of resistance to antineoplastic chemotherapy drugs.
Journals
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors. Archiv der Pharmazie. 2022, 355(12), e2200419, ISSN: 0365-6233, PMID: 36109178,
Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET. Molecular Oncology. 2021, 16(7), 1541-1554, ISSN: 1574-7891, PMID: 34632694,